ADS-ADEA 2015* Karen Jones
The University of Adelaide, SA, Australia
- This delegate is presenting an abstract at this event.
- Other Allied Health
Presentations this author is a contributor to:
Five weeks of resveratrol supplementation has no effect on GLP-1 secretion, gastric emptying, or glycemic control in type 2 diabetes (#375)
2:00 PM
Michelle J Bound
ADEA Poster Viewing One
Relationships of ‘Early’ And ‘Late’ Glycaemic Responses With Gastric Emptying During An Oral Glucose Tolerance Test In Subjects With Normal Glucose Tolerance, Impaired Glucose Tolerance And Type 2 Diabetes (#285)
2:00 PM
Chinmay S Marathe
ADS Clinical Poster Viewing: Glycaemia/Monitoring
The glucagon-like peptide-1 (GLP-1) receptor agonist, exenatide, inhibits small intestinal motility, flow, transit and absorption of glucose in health and type 2 diabetes: a randomised controlled trial. (#71)
4:15 PM
Chinmay S Marathe
ADS Clinical Orals: Gut and Glycaemia
Effects of exenatide on the blood pressure and heart rate responses to intraduodenal glucose in type 2 diabetes (#168)
4:30 PM
Chinmay S Marathe
ADS Clinical Orals: Therapies for Type 2 Diabetes